Auctus Surgical

Executive Summary

Auctus Surgical is a privately held medical device company focused on transforming the treatment of pediatric scoliosis through innovative, growth-friendly spinal correction technology. Founded in 2015 and headquartered in San Jose, California, the company addresses a significant unmet need in children's orthopedics: current surgically implanted growing rods require frequent invasive lengthening procedures, imposing substantial morbidity, cost, and psychological burden on patients and families. Auctus's novel approach aims to enable gradual, dynamic correction of spinal curvature as the child grows, potentially eliminating or reducing the number of revision surgeries. Their proprietary platform leverages advancements in materials and biomechanics to provide adjustable, minimally invasive correction that adapts to the growing spine. While the company remains in early development stages with limited public disclosures, its focus on a clear clinical need and innovative engineering positions it as a compelling player in the pediatric orthopedic device space. If successful, Auctus could capture a meaningful share of the growing pediatric scoliosis market, which lacks truly disruptive solutions. The company's trajectory will hinge on achieving key regulatory and clinical milestones in the near term.

Upcoming Catalysts (preview)

• Q4 2026FDA IDE approval for first-in-human pivotal trial60% success
• Q2 2027Completion of first-in-human proof-of-concept study results50% success
• Q2 2026Strategic partnership with a major pediatric orthopedic device company40% success